Cargando…
Targeting c-MYC with T-Cells
Over-expression of the proto-oncogene c-MYC is frequently observed in a variety of tumors and is a hallmark of Burkitt´s lymphoma. The fact that many tumors are oncogene-addicted to c-MYC, renders c-MYC a powerful target for anti-tumor therapy. Using a xenogenic vaccination strategy by immunizing C5...
Autores principales: | Helm, Florian, Kammertoens, Thomas, Lehmann, Frank M., Wilke, Andrea, Bruns, Heiko, Mautner, Josef, Bornkamm, Georg W., Gerbitz, Armin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795085/ https://www.ncbi.nlm.nih.gov/pubmed/24130880 http://dx.doi.org/10.1371/journal.pone.0077375 |
Ejemplares similares
-
Humanized c-Myc Mouse
por: Lehmann, Frank M., et al.
Publicado: (2012) -
Stromal Interferon-γ Signaling and Cross-Presentation Are Required to Eliminate Antigen-Loss Variants of B Cell Lymphomas in Mice
por: Gerbitz, Armin, et al.
Publicado: (2012) -
Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins
por: Adhikary, Dinesh, et al.
Publicado: (2006) -
Virus and Autoantigen-Specific CD4+ T Cells Are Key Effectors in a SCID Mouse Model of EBV-Associated Post-Transplant Lymphoproliferative Disorders
por: Linnerbauer, Stefanie, et al.
Publicado: (2014) -
Immunodominance of Lytic Cycle Antigens in Epstein-Barr Virus-Specific CD4+ T Cell Preparations for Therapy
por: Adhikary, Dinesh, et al.
Publicado: (2007)